CD44 and neoplasm: CD44, a commonly used tumor stem cell marker in EC, can self-renew and rebuild tumor tissues and is notably expressed in ESCCs with high TDO2 expression, indicating its potential role in tumor recurrence, metastasis, and drug resistance [38].